Long-term prognosis after interferon therapy in chronic hepatitis type C
Inoue, O.; Yano, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 52(7): 1828-1831
1994
ISSN/ISBN: 0047-1852 PMID: 7521425 Document Number: 438341
263 patients with chronic hepatitis C who received interferon therapy were followed up for an average 2.7 years after therapy. 36% of patients showed complete response, 16% of patients showed partial response, 48% of patients showed no response. 96 patients underwent liver biopsy after therapy and were observed long-term prognosis. 13 cases developed to liver cirrhosis. Histopathology before and after interferon, HCV-DNA probe before therapy were examined.
Document emailed within 1 workday
Related Documents
Sampliner, R.E. 1991: Long-term effect of alpha-interferon therapy in chronic hepatitis B American Journal of Gastroenterology 86(12): 1838-1839Perasso, A.; Testino, G.; Sumberaz, A.; Ansaldi, F. 1996: Long-term therapy with interferon in anti-HCV positive chronic hepatitis: is it conceivable? Minerva Medica 87(3): 69-74
Hige, S.; Matsushima, T.; Karino, Y.; Toyota, J. 1995: Long-term prognosis of patients with chronic hepatitis B from the standpoint of the effects of IFN therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 53 Suppl (Part 2): 594-599
Kuloğlu, Z.; Kansu, A.; Erden, E.; Girgin, N. 2010: Efficacy of combined interferon alpha and long-term lamivudine therapy in children with chronic hepatitis B Turkish Journal of Pediatrics 52(5): 457-463
Bernardinello, E.; Cavalletto, L.; Chemello, L.; Mezzocolli, I.; Donada, C.; Benvegnú, L.; Merkel, C.; Gatta, A.; Alberti, A. 1999: Long-term clinical outcome after beta-interferon therapy in cirrhotic patients with chronic hepatitis C. TVVH Study Group Hepato-Gastroenterology 46(30): 3216-3222
Tran, A.; Longo, F.; Saint-Paul, M.C.; Doglio, A.; Benzaken, S.; Rampal, P. 2000: Long-term lamivudine therapy for interferon-alpha- and/or adenine arabinoside monophosphate-resistant chronic hepatitis B infection. Results of a pilot study Gastroenterologie Clinique et Biologique 24(12): 1234-1235
Saito, Y.; Saito, H.; Tada, S.; Nakamoto, N.; Horikawa, H.; Kurita, S.; Kitamura, K.; Ebinuma, H.; Ishii, H.; Hibi, T. 2005: Effect of long-term interferon therapy for refractory chronic hepatitis c: preventive effect on hepatocarcinogenesis Hepato-Gastroenterology 52(65): 1491-1496
Teuber, G.; Dienes, H.P.; Meyer Zum Büschenfelde, K.H.; Gerken, G. 1996: Long-term follow-up of patients with chronic hepatitis B after interferon treatment Zeitschrift für Gastroenterologie 34(4): 230-236
Fujiyama, S.; Tanaka, M. 2000: Hepatitis C: epidemiology and therapy--with special reference to long-term prognosis after IFN therapy Rinsho Byori. Japanese Journal of Clinical Pathology 48(1): 5-13
Marinucci, G.; Hassan, G.; Di Giacomo, C.; Barlattani, A.; Costa, F.; Rasshofer, R.; Roggendorf, M. 1991: Long term treatment of chronic delta hepatitis with alpha recombinant interferon Progress in Clinical and Biological Research 364: 405-410
Ishibashi, K.; Kashiwagi, T.; Ito, A.; Tanaka, Y.; Nagata, T.; Tamaki, J.; Azuma, M.; Kishida, Y.; Yoshida, A.; Hikiji, A.Y. 1995: Predictive factors for efficacy of interferon therapy in chronic hepatitis type C Hepato-Gastroenterology 42(5): 535-541
Zielińska, W.; Korczak-Rogoń, A.; Paszkiewicz, J.; Kowalik, M.; Cummins, J.M.; Georgiades, J.A. 1996: Comparison of the long-term effects of treatment with oral and parenteral interferon alpha in chronic viral hepatitis patients Archivum Immunologiae et Therapiae Experimentalis 44(5-6): 359-366
Procházka, V.; Pohlídalová, L. 1983: Unexpected regression of chronic hepatitis type B after a long-term course Casopis Lekaru Ceskych 122(38): 1165-1171
Rakela, J.; Redeker, A.G.; Weliky, B. 1983: Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis Gastroenterology 84(5 Part 1): 956-960
Obert, H.J.; Brzoska, J.F. 1989: Interferon gamma in the treatment of chronic polyarthritis. Long-term therapy in clinical practice Arzneimittel-Forschung 39(7): 819-822
De Groote, J.; Maes, H.; Vandenbroucke, J. 1970: Long-term therapy of chronic hepatitis Deutsche Zeitschrift für Verdauungs- und Stoffwechselkrankheiten 30(1): 15-17
Pawłowska, M.łg.; Halota, W. 2011: Long-term therapy with nucleoside analog entecavir (baraclude) in patients with chronic hepatitis B Przeglad Epidemiologiczny 65(2): 313-317
Juszczyk, J. 2003: Place of consensus type interferon alpha in the management of chronic type C hepatitis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 14(82): 275-278
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Menninger, H.; Burkhardt, H. 1983: Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents Fortschritte der Medizin 101(14): 639-645